Holen Sie sich die Stockscreener-App
1.19
4.03%
-0.05
Handel nachbörslich:
1.17
-0.02
-1.68%
Schlusskurs vom Vortag:
$1.24
Offen:
$1.2
24-Stunden-Volumen:
171.69K
Relative Volume:
0.33
Marktkapitalisierung:
$10.78M
Einnahmen:
$895.50K
Nettoeinkommen (Verlust:
$-26.30M
KGV:
-0.0181
EPS:
-65.5728
Netto-Cashflow:
$-23.84M
1W Leistung:
+0.85%
1M Leistung:
+2.59%
6M Leistung:
-35.33%
1J Leistung:
-77.72%
1-Tages-Spanne:
$1.1627
$1.26
1-Wochen-Bereich:
$1.15
$1.60
52-Wochen-Spanne:
$0.92
$8.20
Mainz Biomed N V Stock (MYNZ) Company Profile
Firmenname
Mainz Biomed N V
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie MYNZ mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MYNZ
Mainz Biomed N V
|
1.19 | 11.23M | 895.50K | -26.30M | -23.84M | -65.57 |
|
TMO
Thermo Fisher Scientific Inc
|
578.61 | 222.48B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
218.89 | 155.25B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
670.46 | 54.04B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
230.15 | 40.13B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
133.85 | 37.78B | 6.95B | 1.30B | 1.15B | 4.5696 |
Mainz Biomed N V Stock (MYNZ) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-14 | Eingeleitet | Maxim Group | Buy |
| 2024-11-25 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2023-11-21 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-21 | Eingeleitet | H.C. Wainwright | Buy |
Mainz Biomed N V Aktie (MYNZ) Neueste Nachrichten
What’s the beta of Mainz Biomed N.V. stockWeekly Trend Recap & AI Forecasted Entry/Exit Points - mfd.ru
Growth Recap: How does Mainz Biomed NV compare to its peers2025 Support & Resistance & AI Powered Market Trend Analysis - baoquankhu1.vn
Aug Analyst Calls: Is Maplebear Inc stock a buy or sellJuly 2025 Big Picture & High Return Trade Guides - baoquankhu1.vn
Mainz Biomed N.V. to Present Innovative Cancer Detection Research at AACR 2026 Annual Meeting - Quiver Quantitative
Mainz Biomed to Present Results of Pancreatic Cancer Verification Study at AACR 2026 Annual Meeting - GlobeNewswire
Income Plays: How does Mainz Biomed NV compare to its peers2025 Sector Review & Risk Managed Investment Strategies - baoquankhu1.vn
CEO Moves: Will Mainz Biomed NV stock continue upward momentum - Bộ Nội Vụ
Trading Action: Why Mainz Biomed NV stock could outperform in 2025 - moha.gov.vn
Is Mainz Biomed N.V. (4TO) stock among top earnings playsWeekly Market Summary & AI Forecasted Stock Moves - Улправда
Is Mainz Biomed N.V. stock a safe buy before earningsMarket Weekly Review & Low Risk High Reward Ideas - Улправда
Earnings Report: Will Mainz Biomed N.V. stock see PE expansionJuly 2025 Big Picture & Entry Point Strategy Guides - ulpravda.ru
Entry Recap: How resilient is Mainz Biomed N.V. stock in market downturns2025 Growth vs Value & Low Drawdown Momentum Trade Ideas - ulpravda.ru
Is Mainz Biomed N.V. (4TO) stock undervalued after correction2025 Technical Patterns & Fast Exit and Entry Strategy Plans - Улправда
How strong is Mainz Biomed N.V. stock revenue growthMarket Sentiment Indicators & Big Gains Small Capital - ulpravda.ru
Is Mainz Biomed N.V. stock a buy for dividend growthStock Screening Results & Minimal Investment Portfolio - Улправда
Retail Trends: Will Mainz Biomed NV stock see PE expansionWeekly Profit Analysis & Safe Capital Growth Tips - moha.gov.vn
Mainz Biomed Provides Review of 2025 Highlights - Chartmill
Mainz BioMed N.V. / NL0015000LC2 - AD HOC NEWS
Earnings Risk: Why analysts upgrade Pony AI Inc Depositary Receipt stock2025 Short Interest & Weekly Consistent Profit Watchlists - moha.gov.vn
Is Mainz Biomed NV a good long term investmentBullish Engulfing Patterns & Insights From Wall Street Professionals - earlytimes.in
Form 424B5 MAINZ BIOMED N.V. - StreetInsider
Mainz Biomed (NASDAQ:MYNZ) Upgraded by Wall Street Zen to Hold Rating - Defense World
Mainz Biomed (NASDAQ:MYNZ) Stock Price Up 2.7% – Still a Buy? - Defense World
Why retail investors favor Mainz Biomed N.V. stockSwing Trade & Fast Gaining Stock Strategy Reports - Улправда
Why Mainz Biomed N.V. (4TO) stock is a strong buy callJuly 2025 Trade Ideas & AI Driven Price Predictions - Улправда
Why Mainz Biomed N.V. stock remains undervalued2025 EndofYear Setup & Risk Controlled Stock Pick Alerts - Улправда
Will Mainz Biomed N.V. stock reach all time highs in 20252025 Year in Review & Weekly Watchlist of Top Performers - Улправда
How Mainz Biomed N.V. stock reacts to inflationary pressuresJuly 2025 Sector Moves & Verified Momentum Watchlists - ulpravda.ru
2 Small-Cap Biotechs That Could Reward Patient Investors - Investing.com
2 Small-Cap Biotechs That Could Reward Patient Investors - sharewise.com
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Is Mainz Biomed N.V. stock positioned for long term growthJuly 2025 News Drivers & AI Forecast Swing Trade Picks - Newser
Mainz Biomed (Nasdaq: MYNZ) targets $150M shelf to advance cancer diagnostics - Stock Titan
Why Mainz Biomed N.V. (4TO) stock attracts wealthy investorsWeekly Market Outlook & Stock Portfolio Risk Control - Newser
Can Mainz Biomed N.V. (4TO) stock sustain free cash flow2025 Top Gainers & Fast Moving Stock Trade Plans - Newser
Is Mainz Biomed N.V. (4TO) stock expanding market penetrationJuly 2025 News Drivers & AI Forecast Swing Trade Picks - Newser
DoctorBox Adds Mainz Biomed's ColoAlert to Its Portfolio - marketscreener.com
Why Mainz Biomed N.V. (4TO) stock is favored by hedge fundsProduct Launch & Weekly High Conviction Ideas - Newser
Mainz Biomed (MYNZ) Stock Analysis Report | Financials & Insights - Benzinga
DoctorBox Adds Mainz Biomed’s ColoAlert(R) to Its Portfolio - GlobeNewswire
Mainz Biomed (NASDAQ: MYNZ) brings ColoAlert to DoctorBox for colorectal screening - Stock Titan
Weekly Trades: Why hedge funds are buying Mainz Biomed N.V. stockJobs Report & Reliable Price Breakout Alerts - moha.gov.vn
Mainz Biomed N.V (MYNZ) looking to reclaim success with recent performance - Setenews
Mainz Biomed launches up to $2.6M at-the-market stock sale - Stock Titan
Mainz Biomed (NASDAQ:MYNZ) Shares Down 5.8% – What’s Next? - Defense World
Will Mainz Biomed N.V. stock see insider buyingJuly 2025 Closing Moves & Daily Profit Maximizing Trade Tips - newser.com
Is Mainz Biomed N.V. stock positioned well for digital economy2025 Bull vs Bear & Reliable Price Breakout Signals - newser.com
Is Mainz Biomed N.V. (4TO) stock attractive for dividend growth - newser.com
What’s the recovery path for long term holders of Mainz Biomed N.V.Earnings Growth Report & Stepwise Swing Trade Plans - newser.com
Can Mainz Biomed N.V. stock continue upward trend2025 Biggest Moves & Trade Opportunity Analysis Reports - newser.com
Finanzdaten der Mainz Biomed N V-Aktie (MYNZ)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.19%
0.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):